◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › B › BLFS

BioLife Solutions Inc (BLFS) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-13

BioLife Solutions Inc (BLFS) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Bothell, United States with about 155 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, BLFS reported $96M in revenue and ($12M) in net income.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Interactive charts & full statements → Open the BLFS valuation workbench →

BLFS Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$103M	$96M	$82M	$68M	$76M	$119M	$48M	$27M	$20M	$11M	$8M	$6M	$6M	$9M	$6M	$3M	$2M	$2M	$1M	$1M	$1M
Gross Profit	$66M	$62M	$54M	$41M	$47M	$37M	$24M	$18M	$14M	$7M	$5M	$4M	$3M	$4M	$2M	$1M	$1M	$1M	$1M	$1M	$0M
Gross Margin %	64.5%	64.6%	65.2%	60.8%	61.5%	31.1%	50.8%	64.0%	68.5%	61.2%	58.1%	59.2%	49.0%	42.0%	40.5%	50.9%	41.1%	36.3%	41.7%	52.4%	50.6%
Operating Income (EBIT)	$7M	($1M)	($7M)	($19M)	($6M)	($31M)	($3M)	$0M	$4M	($1M)	($5M)	($5M)	($3M)	$0M	($1M)	($1M)	($1M)	($2M)	($2M)	($3M)	($1M)
Operating Margin %	7.2%	-1.1%	-8.7%	-28.5%	-7.8%	-25.7%	-6.9%	-0.8%	18.6%	-9.6%	-59.0%	-77.8%	-50.6%	-3.2%	-16.6%	-43.9%	-67.0%	-144.6%	-186.3%	-279.1%	-247.7%
Net Income	$50M	($12M)	($20M)	($68M)	($140M)	($9M)	$3M	($2M)	$3M	($3M)	($7M)	($4M)	($3M)	($1M)	($2M)	($2M)	($2M)	($3M)	($3M)	($3M)	($1M)
Net Margin %	49.1%	-12.6%	-24.5%	-100.0%	-183.4%	-7.5%	5.5%	-6.0%	16.5%	-22.8%	-83.6%	-65.3%	-52.0%	-12.1%	-29.3%	-70.9%	-95.3%	-175.0%	-209.8%	-293.3%	-188.0%
EBITDA	$10M	$4M	$2M	($7M)	($3M)	($18M)	$2M	$3M	$4M	($1M)	($7M)	($5M)	($3M)	$0M	($1M)	($1M)	($1M)	($2M)	($2M)	($3M)	($1M)
Earnings Per Share (EPS)	$1.02	$-0.25	$-0.44	$-1.56	$-3.29	$-0.23	$0.10	$-0.09	$0.20	$-0.19	$-0.54	$-0.35	$-0.31	$-0.22	$-0.33	$-0.39	$-0.40	$-0.56	$-0.56	$-0.57	$-0.30
Shares Outstanding (M)	49M	49M	46M	44M	42M	39M	27M	19M	16M	13M	13M	12M	10M	5M	5M	5M	5M	5M	5M	5M	4M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLFS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$28M	$28M	$19M	$28M	$25M	$24M	($3M)	$31M
Gross Profit	$18M	$17M	$13M	$18M	$16M	$16M	$8M	$22M
Gross Margin %	64.2%	63.3%	67.5%	63.8%	64.6%	65.9%	-241.6%	71.3%
Operating Income (EBIT)	$2M	$0M	$6M	$0M	($17M)	($1M)	$1M	($2M)
Operating Margin %	6.0%	0.1%	31.0%	-0.3%	-65.5%	-5.1%	-40.5%	-5.1%
Net Income	$45M	$1M	$4M	$1M	($16M)	$0M	$12M	($2M)
Net Margin %	158.4%	4.3%	18.8%	2.2%	-62.3%	-1.9%	-363.9%	-5.6%
EBITDA	$3M	$1M	$5M	$1M	($14M)	$0M	$7M	$1M
Earnings Per Share (EPS)	$0.91	$0.02	$0.07	$0.01	$-0.33	$-0.01	$0.26	$-0.04
Shares Outstanding (M)	49M	49M	49M	49M	48M	47M	48M	46M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLFS Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$17M	$20M	$8M	($12M)	($8M)	($5M)	$7M	$1M	$2M	$1M	($4M)	($5M)	($3M)	$0M	$1M	($1M)	($1M)	($2M)	($2M)	($3M)	($1M)
Capital Expenditures (CapEx)	$18M	$20M	$3M	$6M	$10M	$8M	$5M	$1M	$0M	$0M	$1M	$1M	$1M	$0M	$1M	$0M	$0M	$0M	$0M	$0M	$0M
Free Cash Flow (FCF)	($1M)	$0M	$5M	($19M)	($19M)	($13M)	$2M	$1M	$2M	$0M	($6M)	($6M)	($4M)	$0M	$0M	($1M)	($1M)	($3M)	($2M)	($3M)	($1M)
FCF Margin %	-1.2%	0.4%	6.3%	-27.8%	-24.8%	-11.1%	3.9%	2.0%	9.4%	4.2%	-67.9%	-99.1%	-60.6%	-1.0%	-5.2%	-39.3%	-61.5%	-176.2%	-163.3%	-289.5%	-124.0%
Dividends Paid	—	—	—	—	—	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLFS Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$6M	$0M	$5M	$6M	$7M	$2M	$2M	$5M
Capital Expenditures (CapEx)	$0M	$0M	$14M	$3M	$2M	$0M	$1M	$1M
Free Cash Flow (FCF)	$6M	($1M)	($10M)	$3M	$6M	$2M	$1M	$4M
FCF Margin %	21.7%	-2.4%	-50.9%	10.0%	22.1%	6.5%	-17.0%	12.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLFS Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$447M	$406M	$399M	$413M	$450M	$554M	$235M	$93M	$45M	$12M	$8M	$12M	$16M	$3M	$3M	$2M	$1M	$1M	$1M	$1M	$1M
Cash & Cash Equivalents	$24M	$33M	$95M	$28M	$19M	$70M	$90M	$6M	$31M	$7M	$1M	$4M	$3M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Total Liabilities	$27M	$34M	$51M	$75M	$86M	$76M	$30M	$49M	$31M	$2M	$5M	$3M	$2M	$17M	$16M	$13M	$11M	$9M	$6M	$3M	$0M
Total Debt (Short + Long-Term)	$3M	$7M	$17M	$26M	$29M	$10M	$2M	$1M	$0M	$0M	$6M	$0M	$0M	$11M	$11M	$10M	$9M	$8M	$5M	$3M	$0M
Total Shareholders' Equity	$420M	$372M	$349M	$338M	$364M	$478M	$205M	$83M	$15M	$10M	$3M	$9M	$12M	($13M)	($12M)	($11M)	($10M)	($8M)	($5M)	($2M)	$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLFS viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

NVST · Envista Holdings Corp — $4 billion
ATRC · AtriCure Inc — $3 billion
XRAY · Dentsply Sirona Inc — $2 billion
LMAT · LeMaitre Vascular Inc — $2 billion
AZTA · Azenta Inc — $1 billion
KMTS · Kestra Medical Technologies, Ltd. Common Stock — $1 billion
STAA · STAAR Surgical Company — $1 billion
MDLN · Medline Inc. Class A Common Stock — $43 billion

← BLES All “B” companies BLGB →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.